Skip to main content

Allen Institute for Cell Science releases first disease cell line collection to accelerate discovery

Developing a “disease in a dish” to help treat disease in the body.


1 min read

Texture Background Image Texture Background Image

Hypertrophic cardiomyopathy (HCM) is a common genetic heart condition that can lead to sudden cardiac-related death in young people. Scientists at the Allen Institute for Cells Science have developed a collection of human induced pluripotent stem cell lines to empower the global scientific community to better study and understand this disease under controlled conditions – developing a “disease in a dish” to help treat disease in the body. These cell lines are openly available in the Allen Cell Collection to accelerate research towards more effective treatments and therapies. Learn how these new tools will advance study—and hopefully treatment—of common genetic heart conditions.

About the Allen Institute

The Allen Institute is an independent, 501(c)(3) nonprofit research organization founded by philanthropist and visionary, the late Paul G. Allen. The Allen Institute is dedicated to answering some of the biggest questions in bioscience and accelerating research worldwide. The Institute is a recognized leader in large-scale research with a commitment to an open science model. Its research institutes and programs include the Allen Institute for Brain Science, launched in 2003; the Allen Institute for Cell Science, launched in 2014; the Allen Institute for Immunology, launched in 2018; and the Allen Institute for Neural Dynamics, launched in 2021. In 2016, the Allen Institute expanded its reach with the launch of The Paul G. Allen Frontiers Group, which identifies pioneers with new ideas to expand the boundaries of knowledge and make the world better. For more information, visit

Science Programs at Allen Institute